Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease (Q39397373)

11 September 2017

Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease (English)

1 reference

11 September 2017

Erdheim-Chester disease

0 references

Giulio Cavalli

7

0 references

Elisabetta Ferrero

Elisabetta Ferrero

1

0 references

Marina Ferrarini

Marina Ferrarini

14

0 references

Angelo Corti

Angelo Corti

2

0 references

Claudio Doglioni

Claudio Doglioni

12

0 references

Alvise Berti

Alvise Berti

6

0 references

Lorenzo Dagna

Lorenzo Dagna

13

0 references

Zahir Amoura

11

Zahir Amoura

1 reference

11 September 2017

3

Julien Haroche

1 reference

11 September 2017

8

Corrado Campochiaro

1 reference

11 September 2017

Daniela Belloni

4

1 reference

11 September 2017

Barbara Colombo

5

1 reference

11 September 2017

Antonello Villa

9

1 reference

11 September 2017

Fleur Cohen-Aubart

10

1 reference

11 September 2017

5 May 2016

1 reference

11 September 2017

1 reference

11 September 2017

5

1 reference

11 September 2017

7

1 reference

11 September 2017

e1181244

1 reference

Cardiovascular manifestations of Erdheim-Chester disease

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

Chromogranin A: a paradoxical player in angiogenesis and vascular biology

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

The surging role of Chromogranin A in cardiovascular homeostasis

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

Oncogene-induced senescence as a new mechanism of disease: the paradigm of erdheim-chester disease

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

Regulation and dysregulation of tumor necrosis factor receptor-1.

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

The multifaceted clinical presentations and manifestations of Erdheim-Chester disease: comprehensive review of the literature and of 10 new cases.

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

A new chromogranin A-dependent angiogenic switch activated by thrombin

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

Prognostic value of circulating chromogranin A levels in acute coronary syndromes

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties.

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disorders

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

14 September 2017

Erdheim-Chester disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

TNF-α in Erdheim-Chester disease pericardial effusion promotes endothelial leakage in vitro and is neutralized by infliximab

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5006912

21 August 2018

Über Lipoidgranulomatose

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2016.1181244

Chromogranin A and tumor necrosis factor-alpha (TNF) in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2016.1181244

Tumor Necrosis Factor α As a Master Regulator of Inflammation in Erdheim-Chester Disease: Rationale for the Treatment of Patients With Infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2016.1181244

Circulating chromogranin A reveals extra-articular involvement in patients with rheumatoid arthritis and curbs TNF- -elicited endothelial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2016.1181244

Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F2162402X.2016.1181244

21 January 2018

Erdheim-Chester disease

1 reference

12 December 2020

Immunohistochemical evidence of a cytokine and chemokine network in three patients with Erdheim-Chester disease: Implications for pathogenesis

1 reference

12 December 2020

Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage

1 reference

12 December 2020

Erdheim-Chester disease: report on a case and new insights on its immunopathogenesis

1 reference

12 December 2020

Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients

1 reference

12 December 2020

Erdheim-Chester disease harboring the BRAF V600E mutation

1 reference

12 December 2020

Plasma chromogranin a in patients with inflammatory bowel disease

1 reference

12 December 2020

10.1080/2162402X.2016.1181244

Identifiers

DOI

1 reference

11 September 2017

1 reference

11 September 2017

PubMed publication ID

27622037

1 reference